Biography

Chris Chapman is Counsel in Weil’s Antitrust practice and his expertise includes advising on all aspects of EU and UK competition law including merger control, cartel and abuse of dominance investigations, sector inquiries, as well as appeal processes before the UK and European courts. Prior to joining Weil, Chris was a senior associate at a Magic Circle firm in London and also spent 18 months in-house at the UK telecoms and media regulator, Ofcom.
Chris’ experience encompasses a broad range of industries, including telecommunications, media, pharmaceuticals, healthcare, energy, transport, consumer goods, and industrial/manufacturing sectors. Chris also has particular experience advising clients on the interface between competition law and sectoral regulation.
Representative experience from his previous firm includes:
- Telefónica SA on the £31 billion merger of O2 and Virgin Media with Liberty Global plc, including the CMA Phase 2 investigation
- A number of CMA investigations under the Competition Act 1998 in relation to alleged excessive and unfair pricing and anti-competitive agreements in the pharmaceutical sector
- A crematoria operator on the CMA market investigation under the Enterprise Act 2002 into funeral markets
- An intervenor in Case T-399/16 - CK Telecoms UK Investments v Commission
- Appeal processes before the Competition Appeal Tribunal relating to Ofcom regulatory decisions and CMA investigations
- EE in obtaining unconditional Phase 2 clearance of the £12.5 billion acquisition by BT Group plc
Firm News & Announcements
Latest Thinking
-
Catch me if you can: what next for EU merger policy towards below threshold transactions?
Blog Post — WorthWeil Antitrust Blog
— By
Niklas Maydell,
Annagiulia Zanazzo,
Chris Chapman and
Clémence Coppin
— March 14, 2025
On 10 January 2025, Nvidia brought an action against the European Commission (“EC”)’s decision to review Nvidia’s acquisition of Run:ai, following a referral request from the Italian competition authority under Article 22 of the EU Merger Regulation (“EUMR”). The deal failed to meet both the EUMR and the Italian merger thresholds, and was ‘called in’ ...
- Preparing For Disruptions To Life Sciences Supply Chains Publication — By Kane Wishart, Brianne Kucerik and Chris Chapman — PDF — March 14, 2025
-
A new dawn, a new day for UK merger control: are investors feeling good?
Blog Post — WorthWeil Antitrust Blog
— By
Jenine Hulsmann and
Chris Chapman
— February 17, 2025
A new dawn, a new day for UK merger control: are investors feeling good? In what is shaping up to be the most consequential reform of UK merger control in over a decade, the government and the Competition and Markets Authority (“CMA”) each published on 13 February the equivalent of Jeff Bezos’ “Day 1” letter ...
-
Roll-up, roll-up: What’s next for antitrust scrutiny of serial acquisition strategies?
Blog Post — WorthWeil Antitrust Blog
— By
Megan A. Granger,
Chris Chapman and
Drew Cypher
— February 05, 2025
The FTC announced in the final days of the Biden administration that private equity firm Welsh, Carson, Anderson & Stowe had agreed to a settlement to resolve the FTC’s allegations that it spearheaded its portfolio company’s consolidation of anesthesia clinics in violation of the antitrust laws. But while the Democratic Commissioners portrayed the settlement as a victory for their crusade against serial acquisitions, the Republican Commissioners took issue with their colleagues’ perceived antipathy toward private equity and emphasized that this case is an “ordinary application of the most elementary antitrust principles.” With a Republican now leading the FTC and Republicans soon set to be in the majority, what does this all mean for scrutiny of roll-up strategies going forward? ...
-
Growth will tear us apart? Competition law and the UK government’s growth agenda
Blog Post — WorthWeil Antitrust Blog
— By
Jenine Hulsmann,
Lucy Chambers and
Chris Chapman
— January 28, 2025
Following Marcus Bokkerink’s decision to stand down as Chair of the CMA, the UK government has highlighted the central role which it sees competition policy playing in achieving its pro-growth agenda. In announcing the change, the Secretary of State for Business and Trade emphasised that “we want to see regulators including the CMA supercharging the ...
Firm News & Announcements
- Weil Advises Microsoft in CMA Investigation into Partnership with OpenAI Deal Brief — March 06, 2025
- Weil Advises on CMA’s Ground-breaking Clearance of the Vodafone and Three UK Joint Venture Deal Brief — December 05, 2024